Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HIPK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
H2AFV - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIP12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYCN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYNLT3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSBP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SERINC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
TRAFD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TXNL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PMPCB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DTX3L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OSR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPATCH2L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IMMP2L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on